Halozyme Therapeutics HALO Compensation and benefits
Compensation and benefits at other companies
Other financials
Where this comes from
Reported directly by Halozyme Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The official record: Halozyme Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Halozyme Therapeutics's compensation and benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Halozyme Therapeutics's compensation and benefits?
- Halozyme Therapeutics (HALO) reported compensation and benefits of $16.64M in Q1 2026.
- How has Halozyme Therapeutics's compensation and benefits changed year-over-year?
- Halozyme Therapeutics's compensation and benefits increased by 55.9% year-over-year, from $10.67M to $16.64M.
- What does compensation and benefits mean?
- Total employee-related costs including salaries, wages, bonuses, commissions, stock-based compensation, health insurance, retirement contributions, and payroll taxes.